Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.290EUR
−92.30 MEUR
6.34 MEUR
61.94 M
About Kezar Life Sciences, Inc.
Sector
Industry
CEO
Christopher J. Kirk
Website
Headquarters
South San Francisco
Employees (FY)
58
Founded
2015
FIGI
BBG00L9FNXV8
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange KEZAR LIFE SCIENC.DL-,001 stocks are traded under the ticker 2KZ.
We've gathered analysts' opinions on KEZAR LIFE SCIENC.DL-,001 future price: according to them, 2KZ price has a max estimate of 18.43 EUR and a min estimate of 1.84 EUR. Watch 2KZ chart and read a more detailed KEZAR LIFE SCIENC.DL-,001 stock forecast: see what analysts think of KEZAR LIFE SCIENC.DL-,001 and suggest that you do with its stocks.
Yes, you can track KEZAR LIFE SCIENC.DL-,001 financials in yearly and quarterly reports right on TradingView.
KEZAR LIFE SCIENC.DL-,001 is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
2KZ earnings for the last quarter are −0.28 EUR per share, whereas the estimation was −0.31 EUR resulting in a 10.00% surprise. The estimated earnings for the next quarter are −0.29 EUR per share. See more details about KEZAR LIFE SCIENC.DL-,001 earnings.
KEZAR LIFE SCIENC.DL-,001 revenue for the last quarter amounts to 0 EUR, despite the estimated figure of 617.86 K EUR. In the next quarter, revenue is expected to reach 560.16 K EUR.
2KZ net income for the last quarter is −20.07 M EUR, while the quarter before that showed −29.23 M EUR of net income which accounts for 31.32% change. Track more KEZAR LIFE SCIENC.DL-,001 financial stats to get the full picture.
No, 2KZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 1, 2024, the company has 58.00 employees. See our rating of the largest employees — is KEZAR LIFE SCIENC.DL-,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KEZAR LIFE SCIENC.DL-,001 EBITDA is −95.79 M EUR, and current EBITDA margin is −1.49 K%. See more stats in KEZAR LIFE SCIENC.DL-,001 financial statements.
Like other stocks, 2KZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KEZAR LIFE SCIENC.DL-,001 stock right from TradingView charts — choose your broker and connect to your account.